Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8933084 Macrocyclic compounds as Trk kinase inhibitors

Patent 8933084 was granted and assigned to Array Biopharma Inc. on January, 2015 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 30 Oct, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 30 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12129258 Diaryl macrocyclic compound and pharmaceutical composition, and use thereof
0
Edits on 13 Jun, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 13 Jun, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12006306 Substituted pyridazines as TYK2 inhibitors
0
Edits on 5 Jun, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 5 Jun, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11998545 Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors
0
Edits on 15 May, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 15 May, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11981684 Macrocyclic compounds and uses thereof
0
Edits on 24 Apr, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 24 Apr, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11964988 Fused heterocyclic compounds as RET kinase inhibitors
0
Edits on 30 Jan, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 30 Jan, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11878987 Heterocyclic compound as TRK inhibitor
0
Edits on 27 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 27 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11851434 Substituted pyrazolo[1,5-A]pyrazine compounds as ret kinase inhibitors
0
Edits on 3 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 3 Dec, 2023
Edits made to:
Article (+318 characters)
Article

Patent abstract

Compounds of Formula I: and pharmaceutically acceptable salts thereof, wherein ring A, ring B, W, m, D, R2, R2a, R3, R3a, and Z are as defined herein, are inhibitors of Trk kinases and are useful in the treatment of pain, cancer, inflammation, neurodegenerative diseases and certain infectious diseases.

Edits on 27 Sep, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 27 Sep, 2023
Edits made to:
Infobox (+8 properties)
Infobox
Patent Inventor Names
Gabrielle R. Kolakowski0
HongWoon Yang0
Jeongbeob Seo0
Julia Haas0
Kevin Ronald Condroski0
Qian Zhao0
Steven Wade Andrews0
Yutong Jiang0
Edits on 25 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 25 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 08933084 Macrocyclic compounds as Trk kinase inhibitors US Patent 8933084 Macrocyclic compounds as Trk kinase inhibitors

Infobox
Patent Number
08933084
Patent Number
8933084
Edits on 20 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 20 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=08933084
Edits on 15 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 15 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=08933084
Edits on 28 Dec, 2021
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 28 Dec, 2021
Edits made to:
Infobox (+8 properties)
‌

 US Patent 08933084 Macrocyclic compounds as Trk kinase inhibitors

Infobox
Is a
Patent
Patent
Current assignee
Array Biopharma Inc.
Array Biopharma Inc.
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
08933084
Date of patent
January 13, 2015
Patent application number
13698922
Date Filed
May 13, 2011
Patent primary examiner
‌
Golam M. M. Shameem

Find more entities like US Patent 8933084 Macrocyclic compounds as Trk kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo